Leflunomide Tablet, Film Coated
Product Images NDC 70710-1157

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Leflunomide (NDC 70710-1157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F1c37612 9041 490e 93e9 30e838015b4a 01

FDA Label Image

F1c37612 9041 490e 93e9 30e838015b4a 02

FDA Label Image

F1c37612 9041 490e 93e9 30e838015b4a 03

F1c37612 9041 490e 93e9 30e838015b4a 03
The text is describing the results of a clinical trial evaluating the percentage of patients who achieved ACR 20 response at the endpoint. The trial has been divided into two parts, Trial 1 and Trial 2, and the patients have been treated with different drugs such as Leflunomide, Methotrexate, and Placebo. The data shows the response rate of the patients after two months and six months of treatment.*
FDA Label Image

F1c37612 9041 490e 93e9 30e838015b4a 04

FDA Label Image

F1c37612 9041 490e 93e9 30e838015b4a 05

F1c37612 9041 490e 93e9 30e838015b4a 05
This appears to be a table or a graph and is not available as readable text.*
FDA Label Image

F1c37612 9041 490e 93e9 30e838015b4a 06

FDA Label Image

F1c37612 9041 490e 93e9 30e838015b4a 07

F1c37612 9041 490e 93e9 30e838015b4a 07
This is a label for Leflunomide Tablets, USP that are available in packages of 30 tablets. The tablets contain leflunomide USP (10mg) and the package insert contains the complete prescribing information. The tablets are to be stored at 20° to 25°C (68° to 77°F), which is normal room temperature, and protected from light, and should be kept in a tight container out of reach of children. The product is of Taiwanese origin, manufactured by Cadila Healthcare Ltd., India and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ 08534.*
FDA Label Image

F1c37612 9041 490e 93e9 30e838015b4a 08

F1c37612 9041 490e 93e9 30e838015b4a 08
This is a description for a medication called Leflunomide. Each film-coated tablet contains an unspecified amount of Leflunomide. The medication is stored at 20° to 25°C (68° to 77°F) and should be protected from light. The tablets are manufactured by Cadila Healthcare Ltd. and packed in a tight container with the warning to keep all drugs out of the reach of children. The label also includes a branding for Zydus Pharmaceuticals Inc. with additional codes and numbers that are not clear.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.